bioAffinity Technologies, Inc. Common Stock Share Price
NASDAQ: BIAFHealthcare
Live bioAffinity Technologies, Inc. Common Stock Share Price Chart
O H L
bioAffinity Technologies, Inc. Common Stock Performance Overview
Days Range
▼
$10.39Low
$12.40High
Markets Today
| Previous Close | $8.75 |
|---|---|
| Open | $10.78 |
| Volume | 5,193,927 |
| Day's Range | $10.39 - $12.40 |
| 52W Range | $4.56 - $109.35 |
| Market Cap | $3.21 M |
Historical Performance
| 1M Returns | +23.25 |
|---|---|
| 3M Returns | -30.32 |
| 6M Returns | -75.99 |
| 1Y Returns | -88.50 |
| 5Y Returns | NA |
| 10Y Returns | NA |
bioAffinity Technologies, Inc. Common Stock Fundamentals
| Market Cap | $3.21 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $6.16 M |
| ROE TTM | -3.02 |
| EPS TTM | $-103.36 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.64 |
| EBITDA | $-10.07 M |
| Profit Margin | -241.96 |
| Market Cap | $3.21 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $6.16 M |
| ROE TTM | -3.02 |
| EPS TTM | $-103.36 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.64 |
| EBITDA | $-10.07 M |
| Profit Margin | -241.96 |
bioAffinity Technologies, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.85 M | $1.27 M | $1.45 M | $1.59 M | $1.35 M | $1.51 M |
| Gross Profit + | $1.85 M | $1.27 M | $503.86 K | $692.69 K | $1.35 M | $1.51 M |
| Operating Income | -$2.63 M | -$2.52 M | -$2.29 M | -$3.14 M | -$3.62 M | -$3.33 M |
| EBITDA | -$2.47 M | -$2.40 M | -$2.18 M | -$3.01 M | -$3.50 M | -$3.27 M |
| Interest Expense | -$15.48 K | -$10.46 K | -$5.36 K | -$13.07 K | -$14.72 K | -$11.69 K |
| Depreciation | $154.59 K | $113.23 K | $113.36 K | $123.66 K | $114.52 K | $61.56 K |
| Income Before Tax | -$2.65 M | -$4.03 M | -$5.05 M | -$3.13 M | -$3.63 M | -$3.37 M |
| Income Tax Expense | $8.70 K | $28.98 K | $3.18 K | $3.18 K | $0 | $0 |
| Net Income + | -$2.66 M | -$4.06 M | -$5.05 M | -$3.14 M | -$3.63 M | -$3.37 M |
| Net Profit Margin | -143.53% | -319.88% | -349.3% | -196.98% | -268.63% | -222.83% |
bioAffinity Technologies, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $124.78 K | $197.24 K | $24.26 K | $31.46 K | $31.46 K | $47.45 K |
| Reserve & Surplus | -$56.30 M | -$60.37 M | -$65.42 M | -$68.55 M | -$72.18 M | -$75.55 M |
| Non-Current Liabilities | $692.47 K | $4.30 M | $284.60 K | $776.95 K | $1.10 M | $1.17 M |
| Current Liabilities | $3.42 M | $2.59 M | $2.36 M | $2.91 M | $3.18 M | $2.68 M |
| Total Liabilities | $4.11 M | $6.89 M | $2.64 M | $3.68 M | $4.28 M | $3.85 M |
| Fixed Assets | $1.14 M | $1.10 M | $1.03 M | $982.40 K | $949.07 K | $1.00 M |
| Current Assets | $1.86 M | $1.67 M | $8.61 M | $7.57 M | $4.34 M | $3.87 M |
| Total Assets | $5.55 M | $4.75 M | $11.55 M | $10.96 M | $7.95 M | $7.62 M |
bioAffinity Technologies, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$2.66 M | -$4.06 M | -$5.05 M | -$3.14 M | -$3.63 M | -$3.37 M |
| Operating Cash Flow | -$1.64 M | -$2.65 M | -$2.48 M | -$2.56 M | -$3.23 M | -$3.20 M |
| Investing Cash Flow | -$50.79 K | -$13.43 K | $3.65 K | -$1 | -$5.66 K | -$89.97 K |
| Financing Cash Flow | $1.03 M | $3.02 M | $9.34 M | $1.34 M | -$118.51 K | $2.62 M |
| Change in Cash | -$660.59 K | $358.13 K | $6.87 M | -$1.22 M | -$3.35 M | -$668.65 K |
bioAffinity Technologies, Inc. Common Stock Return Calculator
The bioAffinity Technologies, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About bioAffinity Technologies, Inc. Common Stock
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
Popular Stocks
FAQs
What is the share price of bioAffinity Technologies, Inc. Common Stock today?
bioAffinity Technologies, Inc. Common Stock (BIAF) share price as of September 18, 2026 is $10.95. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of bioAffinity Technologies, Inc. Common Stock?
Yes, Indian Investors can invest in the bioAffinity Technologies, Inc. Common Stock (BIAF) Share by opening an international trading account with Angel One.
How can I purchase bioAffinity Technologies, Inc. Common Stock shares in India?
Purchasing bioAffinity Technologies, Inc. Common Stock (BIAF) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying bioAffinity Technologies, Inc. Common Stock (BIAF) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of bioAffinity Technologies, Inc. Common Stock?
Yes, you can purchase fractional shares of bioAffinity Technologies, Inc. Common Stock (BIAF) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of bioAffinity Technologies, Inc. Common Stock?
The market capitalization of bioAffinity Technologies, Inc. Common Stock on September 18, 2026, is $3.21 M.
In which sector bioAffinity Technologies, Inc. Common Stock belongs?
bioAffinity Technologies, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in bioAffinity Technologies, Inc. Common Stock stocks?
In order to invest in bioAffinity Technologies, Inc. Common Stock (BIAF) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
